Dorman Products, Inc. (DORM) stock
Close on Nov 17, 2026Market cap $3.85BP/E 19.4Yield –
Earnings
Dorman Products's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Dorman Products's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 24, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 26, 2026 | Oct 26, 2026after the close | $561.70M | +3.3% | $1.98 | $2.08 | Release |
| Q2 FY2026ended Jun 27, 2026 | Aug 3, 2026during market hours | $544.60M | +0.7% | $2.93 | $3.08 | Release |
| Q1 FY2026ended Mar 28, 2026 | May 4, 2026during market hours | $528.80M | +4.2% | $1.43 | $1.57 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026during market hours | $537.90M | +0.8% | $0.38 | $2.17 | Release |
| Q3 FY2025ended Sep 27, 2025 | Oct 27, 2025during market hours | $543.70M | +7.9% | $2.48 | $2.62 | Release |
| Q2 FY2025ended Jun 28, 2025 | Aug 4, 2025during market hours | $541.00M | +7.6% | $1.91 | $2.06 | Release |
| Q1 FY2025ended Mar 29, 2025 | May 5, 2025during market hours | $507.70M | +8.3% | $1.87 | $2.02 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025during market hours | $533.80M | +8.0% | $1.77 | $2.20 | Release |
| Q3 FY2024ended Sep 28, 2024 | Oct 31, 2024during market hours | $503.80M | +3.2% | $1.80 | $1.96 | Release |
| Q2 FY2024ended Jun 29, 2024 | Aug 1, 2024during market hours | $503.00M | +4.7% | $1.53 | $1.67 | Release |
| Q1 FY2024ended Mar 30, 2024 | May 7, 2024before the open | $468.70M | +0.4% | $1.05 | $1.31 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 26, 2024during market hours | $494.30M | -1.4% | $1.60 | $1.57 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 31, 2023before the open | $488.20M | +18.1% | $1.28 | $1.40 | Release |
| Q2 FY2023ended Jul 1, 2023 | Aug 1, 2023before the open | $480.60M | +15.1% | $1.04 | $1.01 | Release |
| Q1 FY2023ended Apr 1, 2023 | May 2, 2023before the open | $466.70M | +16.2% | $0.18 | $0.56 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023before the open | $501.30M | +25.9% | $0.57 | $1.01 | Release |
| Q3 FY2022ended Sep 24, 2022 | Oct 24, 2022before the open | $413.50M | +18.7% | $0.97 | $1.17 | Release |
| Q2 FY2022ended Jun 25, 2022 | Jul 25, 2022before the open | $417.40M | – | $1.20 | $1.29 | Release |
| Q1 FY2022ended Mar 26, 2022 | Apr 25, 2022before the open | $401.60M | – | $1.11 | $1.29 | Release |
| Q4 FY2021ended Dec 25, 2021 | Feb 22, 2022before the open | $398.20M | – | $1.07 | $1.33 | Release |
| Q3 FY2021ended Sep 25, 2021 | Oct 25, 2021before the open | $348.40M | – | $1.04 | $1.18 | Release |
| Q2 FY2021ended Jun 26, 2021 | Jul 26, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 27, 2021 | Apr 26, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 26, 2020 | Feb 22, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 26, 2020 | Oct 28, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Dorman Products's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net sales growthGAAP | FY2026 | +2% – +3% | – | New | Oct 26, 2026 |
| Net Sales Growth vs. 2025 | FY2026 | +3% – +5% | +7% – +9% | Lowered | Aug 3, 2026 |
| diluted EPSGAAP | FY2026 | $7.95 – $8.15 | – | New | Oct 26, 2026 |
| Diluted EPSGAAP | FY2026 | $7.93 – $8.23 | $7.57 – $7.97 | Raised | Aug 3, 2026 |
| adjusted diluted EPSnon-GAAP | FY2026 | $8.50 – $8.70 | – | New | Oct 26, 2026 |
| adjusted diluted EPSnon-GAAP | FY2026 | $8.50 – $8.80 | $8.10 – $8.50 | Raised | Aug 3, 2026 |
| Adjusted Diluted EPS Growth vs. 2025non-GAAP | FY2026 | -4% – -1% | – | New | Aug 3, 2026 |
| Diluted EPS Growth vs. 2025GAAP | FY2026 | +19% – +24% | – | New | Aug 3, 2026 |
| Tax Rate Estimate | FY2026 | 23.5% – 24% | – | New | Oct 26, 2026 |
| Tax Rate Estimate | FY2026 | 23.5% | 23.5% | Reaffirmed | Aug 3, 2026 |
Guidance vs results
The last range Dorman Products gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted Diluted EPS* | $8.60 – $8.90 | $8.87Σ4Q | Within range |
| FY2025 | EPS (GAAP) | $8.05 – $8.35 | $6.64Σ4Q | Below range |
| FY2025 | Revenue growth | +7% – +9% | +6.02%Σ4Q | Below range |
Guidance history
Every forecast Dorman Products put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 26, 2026 | adjusted diluted EPS | FY2026 | $8.50 – $8.70 | New |
| Oct 26, 2026 | diluted EPS | FY2026 | $7.95 – $8.15 | New |
| Oct 26, 2026 | Tax Rate Estimate | FY2026 | 23.5% – 24% | New |
| Oct 26, 2026 | net sales growth | FY2026 | +2% – +3% | New |
| Aug 3, 2026 | adjusted diluted EPS | FY2026 | $8.50 – $8.80 | Raised |
| Aug 3, 2026 | Diluted EPS | FY2026 | $7.93 – $8.23 | Raised |
| Aug 3, 2026 | Tax Rate Estimate | FY2026 | 23.5% | Reaffirmed |
| Aug 3, 2026 | Diluted EPS Growth vs. 2025 | FY2026 | +19% – +24% | New |
| Aug 3, 2026 | Adjusted Diluted EPS Growth vs. 2025 | FY2026 | -4% – -1% | New |
| Aug 3, 2026 | Net Sales Growth vs. 2025 | FY2026 | +3% – +5% | Lowered |
| May 4, 2026 | Adjusted Diluted EPS* | FY2026 | $8.10 – $8.50 | Reaffirmed |
| May 4, 2026 | Diluted EPS | FY2026 | $7.57 – $7.97 | Reaffirmed |
| May 4, 2026 | Tax Rate Estimate | FY2026 | 23.5% | Reaffirmed |
| May 4, 2026 | Net Sales Change vs. 2025 | FY2026 | +7% – +9% | Reaffirmed |
| Feb 25, 2026 | Adjusted Diluted EPS* | FY2026 | $8.10 – $8.50 | New |
| Feb 25, 2026 | Diluted EPS | FY2026 | $7.57 – $7.97 | New |
| Feb 25, 2026 | Tax Rate Estimate | FY2026 | 23.5% | New |
| Feb 25, 2026 | Net Sales Growth vs 2025 | FY2026 | +7% – +9% | New |
| Oct 27, 2025 | Adjusted Diluted EPS* | FY2025 | $8.60 – $8.90 | New |
| Oct 27, 2025 | Diluted EPS | FY2025 | $8.05 – $8.35 | New |
| Oct 27, 2025 | Tax Rate Estimate | FY2025 | 23.5% | New |
| Oct 27, 2025 | Net Sales Growth vs. 2024 | FY2025 | +7% – +9% | New |
| Aug 4, 2025 | adjusted diluted EPS | FY2025 | $8.60 – $8.90 | Raised |
| Aug 4, 2025 | diluted EPS | FY2025 | $8.05 – $8.35 | Raised |
| Aug 4, 2025 | Tax Rate Estimate | FY2025 | 24% | Reaffirmed |
| Aug 4, 2025 | Net Sales Growth vs. 2024 | FY2025 | +7% – +9% | Raised |
| May 5, 2025 | Adjusted Diluted EPS* | FY2025 | $7.55 – $7.85 | Reaffirmed |
| May 5, 2025 | Diluted EPS | FY2025 | $7.00 – $7.30 | Reaffirmed |
| May 5, 2025 | Tax Rate Estimate | FY2025 | 24% | Reaffirmed |
| May 5, 2025 | Net Sales Growth vs. 2024 | FY2025 | +3% – +5% | New |
| Feb 26, 2025 | Adjusted diluted earnings per share (Non-GAAP) | FY2025 | $7.55 – $7.85 | New |
| Feb 26, 2025 | Diluted earnings per share (GAAP) | FY2025 | $7.00 – $7.30 | New |
| Feb 26, 2025 | Tax Rate Estimate | FY2025 | 24% | New |
| Feb 26, 2025 | Net Sales Growth vs 2024 | FY2025 | +3% – +5% | New |
| Oct 31, 2024 | Adjusted Diluted EPS* | FY2024 | $6.85 – $6.95 | Raised |
| Oct 31, 2024 | Diluted EPS | FY2024 | $6.15 – $6.25 | Raised |
| Oct 31, 2024 | Tax Rate Estimate | FY2024 | 24% | Reaffirmed |
| Oct 31, 2024 | Net Sales Growth vs. 2023 | FY2024 | +3.5% – +4.5% | Narrowed |
| Aug 1, 2024 | adjusted diluted EPS* | FY2024 | $6.00 – $6.20 | Raised |
| Aug 1, 2024 | diluted EPS | FY2024 | $5.32 – $5.52 | Raised |
| Aug 1, 2024 | Tax Rate Estimate | FY2024 | 24% | New |
| Aug 1, 2024 | Net Sales Growth vs. 2023 | FY2024 | +3% – +5% | Reaffirmed |
| May 7, 2024 | adjusted diluted EPS* | FY2024 | $5.40 – $5.70 | Reaffirmed |
| May 7, 2024 | diluted EPS | FY2024 | $4.71 – $5.01 | Reaffirmed |
| May 7, 2024 | net sales growth | FY2024 | +3% – +5% | New |
| Feb 26, 2024 | adjusted diluted EPS* | FY2024 | $5.40 – $5.70 | New |
| Feb 26, 2024 | diluted EPS | FY2024 | $4.71 – $5.01 | New |
| Feb 26, 2024 | net sales growth | FY2024 | +3% – +5% | New |
| Oct 31, 2023 | revised adjusted diluted EPS* | Q4 FY2023 | +35% – +55% | New |
| Oct 31, 2023 | Adjusted Diluted EPS* | FY2023 | $4.35 – $4.55 | Lowered |
| Oct 31, 2023 | Diluted EPS | FY2023 | $3.75 – $3.95 | Lowered |
| Oct 31, 2023 | Net Sales | FY2023 | $1.93B – $1.95B | Lowered |
| Aug 1, 2023 | adjusted diluted EPS* | FY2023 | $5.15 – $5.35 | Reaffirmed |
| Aug 1, 2023 | diluted EPS | FY2023 | $4.35 – $4.55 | Reaffirmed |
| Aug 1, 2023 | net sales | FY2023 | $1.95B – $2.00B | New |
| May 2, 2023 | adjusted diluted EPS* | FY2023 | $5.15 – $5.35 | Reaffirmed |
| May 2, 2023 | diluted EPS | FY2023 | $4.35 – $4.55 | Reaffirmed |
| May 2, 2023 | net sales | FY2023 | $1.95B – $2.00B | Reaffirmed |
| Feb 28, 2023 | Adjusted Diluted EPS* | FY2023 | $5.15 – $5.35 | New |
| Feb 28, 2023 | Diluted EPS | FY2023 | $4.35 – $4.55 | New |
| Feb 28, 2023 | Net Sales | FY2023 | $1.95B – $2.00B | New |
| Oct 24, 2022 | Adjusted Diluted EPS* | FY2022 | $4.70 – $4.90 | Lowered |
| Oct 24, 2022 | Tax Rate Estimate | FY2022 | 22.5% | New |
| Oct 24, 2022 | Net Sales | FY2022 | $1.65B – $1.69B | Raised |
| Jul 25, 2022 | adjusted diluted EPS* | FY2022 | $5.00 – $5.20 | Lowered |
| Jul 25, 2022 | diluted EPS | FY2022 | $4.50 – $4.70 | Lowered |
| Jul 25, 2022 | net sales growth guidance | FY2022 | +19% – +22% | Reaffirmed |
| Apr 25, 2022 | adjusted diluted EPS* | FY2022 | $5.35 – $5.55 | Reaffirmed |
| Apr 25, 2022 | diluted EPS | FY2022 | $4.94 – $5.14 | Reaffirmed |
| Apr 25, 2022 | net sales growth | FY2022 | +19% – +22% | New |
| Feb 22, 2022 | adjusted diluted EPS* | FY2022 | $5.35 – $5.55 | New |
| Feb 22, 2022 | diluted EPS | FY2022 | $4.94 – $5.14 | New |
| Feb 22, 2022 | net sales | FY2022 | $1.60B – $1.64B | New |
| Oct 25, 2021 | adjusted diluted EPS* | FY2021 | $4.56 – $4.80 | New |
| Oct 25, 2021 | net sales growth | FY2021 | +19% – +22% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Dorman Products filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- News
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?